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The Use of ex Vivo Rodent Platforms
in Neuroscience Translational
Research With Attention to the 3Rs
Philosophy
Laura Lossi and Adalberto Merighi*
Laboratory of Neurobiology, Department of Veterinary Sciences, University of Turin, Turin, Italy
The principles of the 3Rs—Replacement, Reduction, and Refinement—are at the basis
of most advanced national and supranational (EU) regulations on animal experimentation
and welfare. In the perspective to reduce and refine the use of these animals in
translational research, we here discuss the use of rodent acute and organotypically
cultured central nervous system slices. We describe novel applications of these
ex vivo platforms in medium-throughput screening of neuroactive molecules of potential
pharmacological interest, with particular attention to more recent developments that
permit to fully exploit the potential of direct genetic engineering of organotypic cultures
using transfection techniques. We then describe the perspectives for expanding the use
ex vivo platforms in neuroscience studies under the 3Rs philosophy using the following
approaches: (1) Use of co-cultures of two brain regions physiologically connected to
each other (source-target) to analyze axon regeneration and reconstruction of circuitries;
(2) Microinjection or co-cultures of primary cells and/or cell lines releasing one or more
neuroactive molecules to screen their physiological and/or pharmacological effects onto
neuronal survival and slice circuitry. Microinjected or co-cultured cells are ideally made
fluorescent after transfection with a plasmid construct encoding green or red fluorescent
protein under the control of a general promoter such as hCMV; (3) Use of “sniffer” cells
sensing the release of biologically active molecules from organotypic cultures by means
of fluorescent probes. These cells can be prepared with activatable green fluorescent
protein, a unique chromophore that remains in a “dark” state because its maturation is
inhibited, and can be made fluorescent (de-quenched) if specific cellular enzymes, such
as proteases or kinases, are activated.
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INTRODUCTION
The principles of the 3Rs - Replacement, Reduction and Refinement—were first formulated in 1959
by Russell and Burch (http://altweb.jhsph.edu/pubs/books/humane_exp/het-toc). In the following
decades the interpretation of the 3Rs has somewhat broadened (1) and the 3Rs have been redefined
e.g., by the UK National Centre for the Replacement Refinement & Reduction of Animals in
Research (https://www.nc3rs.org.uk/the-3rs). Nowadays Replacement falls into two categories: full
replacement, where animals are fully substituted by human volunteers or established cell lines,
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methods in silico, or mathematical modeling, and partial
replacement, where animals in lower positions along the
evolutionary scale such as invertebrates or nematodes, or cultures
of primary cells and tissues explanted from animals that are
killed to purpose, and thus have not been employed in a
scientific procedure that produces pain, are employed. When
Replacement involves the use of lower vertebrates (such as
fish) or invertebrates it must be stressed out that there is
still an ongoing debate as regarding the capability of these
animals to experience pain (https://f1000research.com/slides/5-
1348). Reduction occurs when comparable levels of information
from fewer animals are obtained. This often requires an
improved experimental design combined with sound statistics.
If avoiding the use of animals is impossible, Refinement refers
to amelioration of scientific procedures and husbandry, so that
animal welfare is improved and pain or distress reduced to a
minimum.
A logical approach to the 3Rs in neurosciences requires that
several issues specific to this discipline are carefully considered
(2). It is today difficult to envisage the possibility to fully
replace animals in the study of neuronal development, circuits,
cognitive activities, degeneration, and repair. Although more
feasible, at least on theoretical grounds, reduction also poses
some practical problems to researchers. The widespread use
of genetically-modified animals has permitted to develop very
precious models to study the normal and pathological brain,
but, at the same time, has dramatically increased the number
of animals, mainly mice and fish, employed in experimental
procedures. The augmented production and use of these new
animal strains with e.g., gain/loss of function mutations or gene
knock-out/knock-in has been, in fact, the main causal factor
explaining the increased use of rodents (mice) in biomedical
experiments, whereas the use of wild type animals has, on the
other hand, been dropping steadily in the last decades (http://
www.understandinganimalresearch.org.uk/animals/numbers-
animals/#Trends%20over%20time). Refinement is beyond any
doubt easier to be implemented. Amelioration in environmental
conditions (enrichment), veterinary care and experimental
procedures may quite easily reduce suffering and, hence, the
ethical cost of research. At the same time, refinement produces
scientific data of higher quality (3).
The use of animals in neuroscience research raises particularly
harsh ethical issues. Many disorders of the nervous system
are extremely painful and debilitative. The incidence of the
major dementias, such as Alzheimer’s disease, Parkinson’s
disease, motor neuron disorders, and chronic pain syndromes
is increasing in the world population, but still adequate
therapies are lacking. This, from one side, prompts the scientific
community to intensify research, but, from the opposite, finds
very limited understanding in the general public that is anxious
to very rapidly benefit from the results of research. Neuroscience
studies often require the imposition of very distressing and/or
painful conditions to animals, or exerting shrewd or devious
influence on their experience. This has a very high ethical cost
that often appears to conflict with the utilitarian doctrine. The
latter, on the fact that animals may experience physical and
emotional pain, requires that any injury caused to animals is
reduced to a minimum and counterbalanced by the advantages
that can be obtained in return (1). At the same time, public
acceptance (4) is contingent on the understanding that in order to
achieve the greatest advantage for people, other living organisms,
and the environment, the least possible quantity of pain will be
provoked to the least possible number of animals (see https://
www.ipsos.com/en/public-attitudes-animal-research-2016).
EX VIVO RODENT PLATFORMS IN
NEUROSCIENCE RESEARCH
The primary goal of translational biomedical research is the quick
and systematic transfer of the results of basic research to the
human and animal clinics. To accomplish this goal it is required
that basic research is organized in an integrated interdisciplinary
manner in foreseeing potential clinical applications. The level of
complexity of the animal body, from molecules to cells, tissues,
and organs, requires the use of appropriate experimental tools
enabling researchers to find scientifically sound responses to
questions at the basis of their studies. Studies on individual
cells (primary neurons or neuronal cell lines) in vitro have laid
foundations to molecular and cellular neuroscience. However,
when one comes to consider some of the aforementioned major
issues in neuroscience research it becomes immediately clear that
more complex experimental settings are required. Thus, animal
models come into play and choice of the correct model(s) is of
paramount importance for the success of translational studies.
Although not always feasible, if one wants to avoid the use of
intact animals, ex vivo platforms represent a good compromise
under several aspects such as the reduction of the high costs of
research in vivo, the possibility to perform medium-throughput
screening of drugs and molecules of potential therapeutic
application and, last but not least, the compliance with ethical
issues.
The term ex vivo indicates a condition in which a fragment of
a tissue or organ is explanted from the body and maintained in
culture. In principle, this condition is very similar to that in vitro,
but preserves, at least in part, the spatial, and cellular relationship
between the different cellular types contained in the explant.
Today, most ex vivo platforms take the form of a slice cut from
the brain or the spinal cord and are valuable implements to study
the circuits made by neurons in terms of the structure, physiology
and pharmacology, as well as their response to experimental
damage (5, 6). Slices can be fabricated with ease, retain tissue
cytoarchitecture, offer the possibility to carry out several types
of experiments very simply and permit an accurate regulation of
the environment where cells are cultivated. Therefore slice-based
platforms facilitate research aiming to investigate the correlations
between structure and function, as well as the plasticity of
neuronal interactions under normal and pathological conditions.
Finally, these ex vivo platforms may be used for genetic and
molecular screening in basic and translational research.
In neurobiology experiments, one usually employs two types
of slice platforms (6). Short-living (a few hours) slices came into
use mainly as substitutes of electrophysiological experiments in
vivo, when the patch clamp technology was developed. Slices are
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ideal for studying the functional and pharmacological features
of synapses, as terminals remain intact for at least 6–8 h in
this type of preparations. Slices display greater mechanical
stability over the intact animal and permit a careful control
over the composition of the extracellular environment, these
two features being at the basis of their widespread use in the
last decades. In more recent times, in vivo whole-cell patch-
clamp recording was substantially ameliorated and allowed
investigating electrical behavior of single neurons as well the
manner in which they operate in networks in the natural context
of fully connected biological circuits (7). However, whole-cell
patch-clamp recording in vivo is highly demanding in terms
of equipment and technical skill, this explaining why acute
slices still stand the challenge of time. To successfully deal
with the main limit of acute slices, i.e., their short survival,
organotypic cultures (OCs) have been developed as an alternative
for long-term studies. OCs were produced starting from previous
work done on cultured explants from various tissues or organs.
Initial studies employed the so called roller tube technique,
to permit access, and diffusion of oxygen in the thickness of
tissue (5). Brain OCs, as routinely used today, were originally
developed by Gahwiler (8) and retain, at least in part, several
fundamental architectural characteristics of the tissue of origin,
i.e., the connections among neurons, the quantitative ratio of
different neuronal populations, and the relationship between
neurons and glia (8). The subsequent instauration of a culturing
technique based on the use of semiporous membranes (9),
currently referred to as the semipermeable membrane technique
ormembrane interface technique, has further increased the use of
OCs. According to the membrane interface protocol, the brain or
spinal cord is sliced and a few slices are bedded onto a permeable
membrane mounted on a plastic insert. The insert is then put in
a Petri dish that is filled with the culture medium, so that slices
receive nutrients from the underside and oxygen from the top.
Thus they remain alive at the boundary between the O2/CO2
atmosphere of the incubator and the medium, within a thin
fluidic sheet. The main methodological aspects related to the use
of the semipermeable membrane technique have been recently
reviewed (5).
In the fulfillment of the Replacement principle, OCs can
be prepared from simpler organisms than mammals such
as Drosophila (10) or tissues obtained from human patients
(11, 12). However, it is immediately obvious that interest in
their translational use is primarily related to Reduction and
Refinement. Theoretically, OCs can be established from any
species, but the vast majority of studies with OCs are carried
out in rodents, which are the prevalent mammalian species
employed in neuroscience research. This is particularly true for
mice as the development of transgenic models has significantly
increased their use (see above). Besides to small size and limited
requirement of space, there are several advantages connected
to the use of rodents in neuroscience research, but one has
to consider carefully that some anatomical features are unique
to each species (13), thus translation to humans is not always
straight. The length of rodents’ lifespan is important: rodents
typically live less than two years, which, from one side, facilitates
aging studies, but still represents a quite long temporal interval
for follow-up. Therefore, alternative models in aging research
have been proposed such as senescence-accelerated fish (14) or
mouse (15) strains.
Rodent OCs can be prepared from virtually all areas of
the brain (e.g., the olfactory bulb, cerebral and cerebellar
cortices, striatum, hippocampus, basal forebrain, thalamus and
hypothalamus, mesencephalon), the spinal cord, and the retina
[see Table 1 in Lossi et al. (6) for references].
Technical Aspects
This article has not the purpose to address technical details for the
preparation of acute slices or OCs. However, in considering the
possibility to use these preparations according to the Reduction
and Refinement principles it is convenient to recall here that
acute slices and OCs display very different properties.
Slices have the advantage of behaving similarly to the in vivo
situation. Molecules that are released as a consequence of the
preparative procedure and may be toxic to the cells are usually
washed out before electrophysiology or release experiments are
carried out. For example, acute spinal cord slices can be subjected
to challenge with capsaicin, the vanilloid extracted from the red
hot chili pepper, to induce release of sensory neurotransmitters
and mimic the central effects of inflammation (16). Thence,
neurotransmitters are released in the artificial cerebro-spinal
fluid (ACSF) where slices are maintained for short-term survival
and can be quantitated e.g., with ELISA to study the mechanism
and/or modulation of release (17).
In slices, cell survival is not relevant as well as the
disconnection of terminals from their parent neurons. Thus it is
commonly held that neuronal circuits are maintained unaltered,
as well as the neurochemical content and subcellular site(s)
of transmitter storage, in processes/terminals. However, some
authors have reported that the temperature of the ACSF may
influence dendritic spine plasticity (18) and synaptogenesis (6).
Slice thickness is also irrelevant to the success of experiments,
unless it interferes with imaging of specific cell type(s)
tagged with fluorescent reporter proteins (FRPs), calcium
(19, 20)/potassium (21) indicators, or optogenetic probes
(22).
Differently from acute slices, OCs require a period of
adjustment to the ex vivo condition before use. After tissue
explant and slicing, damaged cells release calcium, and glutamate
at toxic concentration. As a consequence, there is a massive
apoptotic cell death in the first days in vitro [DIV—see Figure
3 in Lossi et al. (6)]. Neuronal death can be, at least in part,
counteracted/reduced by adding trophic factors to the medium.
For example, addition of nerve growth factor (NGF) to basal
forebrain OCs protects cholinergic neurons from death that
follows axotomy during the slicing procedure (23). In parallel,
in the same temporal interval, astrocytes proliferate to generate
a more or less thick layer on the upper surface of the OCs [see
Figure 2G in Lossi et al. (6)]. These examples illustrate why it
is necessary to allow a stabilization period of 4-14 DIV before
proceeding to experiments.
Another important issue is the age of donor (5). Explants may
be prepared from embryos, postnatal pups (less than P12 in rats
or mice) or adults. Embryonic, and postnatal tissues are easier to
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be cultivated, but there are increasing reports on the use of OCs
prepared from adult or aged subjects (24).
Structural Changes Following Disconnection of the
Explants From Afferent/Efferent Fibers
Orientation of cut is very important in determining the
subsequent anatomical and physiological properties of the slices,
because, at least in certain instances, one or more specific
pathways can be selectively spared and thus maintained in long-
term OCs.
Axotomy of afferent fibers
Axotomy of afferent fibers during slicing results in terminal
degeneration, transmitter depletion and a profound impact on
structure and physiology (Figures 1, 2). Themode of termination
of the various afferent systems in different types of slices
deeply affects the subsequent structure of OCs (6). In OCs
obtained from the cerebral cortex (Figures 1A,B), afferent fibers,
mostly originating from the thalamus, primarily reach the
granular cells of layers II and IV (25). In hippocampal slices
(Figures 1C,D), afferent fibers mainly derive from entorhinal
cortex and septum. In cerebellar slices (Figures 1E,F) the afferent
mossy and climbing fibers reach, respectively, the granular
and molecular layers. In spinal cord (Figures 2A,B), primary
afferent fibers derive from the neurons the dorsal root ganglia
(DRGs) and terminate in different laminae of the dorsal horn.
The retina (Figures 2C,D) represents a remarkable exception,
because the entire afferent pathway remains contained within the
OC, but the absence of the retinal pigmented epithelium makes
less effective the differentiation of the outer segments of the
photoreceptors.
Axotomy of efferent fibers
Resection of the efferent fibers impacts more or less substantially
onto the survival of their parent neurons (6). Efferent fibers
from the cerebral cortex (Figures 1A,B) derive from the large
pyramidal neurons projecting to the brainstem or the spinal
cord, or the cortico-striatal neurons, both residing in layer
V. Another important contingent originates from the cortico-
thalamic neurons of layer VI. To these, the callosal fibers
interconnecting the two hemispheres should also be added.
In hippocampus (Figures 1C,D), efferent fibers originate from
CA1 and CA3 pyramidal neurons. It is worth noting that
the axons of the granule cells (the mossy fibers) undergo
a fairly large outgrowth, as a consequence of the slicing
procedure (Figure 1D). In cerebellum (Figures 1E,F), efferent
fibers originate from neurons in cerebellar nuclei. Efferent
projections from cerebellar Purkinje neurons may be refrained
from harming if the slice incorporates the nuclear neurons.
Remarkably, a few Purkinje neurons deprived of their target
develop aberrant self-innervation as a consequence of a massive
axonal sprouting. Efferent fibers leaving the spinal cord via the
ventral roots of the spinal nerves are cut during the slicing
procedure (Figures 2A,B). In the retina (Figures 2C,D), efferent
fibers, i.e., the ganglion cells’ axons, are all severed in the explant
with remarkable consequences on survival.
Blood Vessels and Blood-Brain Barrier
(BBB)
Studies carried out after immunocytochemical labeling for some
of the proteins of the endothelium have demonstrated that
capillaries endure very well culture conditions. Therefore, albeit
they are not functional in OCs and there is not blood flow,
still endothelial cells produce and secrete several molecules that
are capable of influencing the activity of the nerve cells and
fibers. This absence of functional capillaries deeply influences
the maintenance of OCs in long-term experiments. With time
cultures become thinner as a mean to permit a more efficient
passive diffusion of oxygen andmetabolites. This has outstanding
consequences on cytoarchitecture. An important development in
perspective is the more and more expanding use of microfluidic
chambers to permit an optimal distribution of nutrients and/or
to selectively target certain areas of the OC rather than the entire
slice (26) and the development of devices for long term perfusion,
imaging, and electrical interfacing (27). It is also of relevance the
possibility to reconstruct in vitro the BBB and use it to condition
the medium in which OCs are grown (28).
The BBB can be reconstructed in vitro e.g., using co-
cultures of bEnd, a mouse immortalized endothelial cell line, and
primary astrocytes from the same species in which the two cell
populations are maintained separated using Transwell filters as a
substrate for cell growth (29).
Transfection of OCs
Introduction of foreign nucleic acids into cells is commonly
referred to as transfection. Initially, the process was developed
for DNA, but, nowadays, not only DNA (DNA transfer) but also
RNA can be experimentally inserted into cells. As nucleic acids
cannot cross the neurolemma, they require to be transported
by a carrier (vector) to pass the cellular membrane. As a
consequence, a stable or a transient transfection is achieved in
relation to the type of nucleic acid introduced into the cell and
the type of vector employed in the procedure. The difference
between the two is relevant as only in stable transfection the
foreign DNA sequence(s) become(s) part host cell genome.
Neurons are in general post-mitotic cells. Therefore, as they
do not replicate their DNA, it is very difficult to transfect
them. For this reason, in most instances gene transfer in
OCs results in a transient transfection that, nonetheless, is
suitable for experiments lasting from a few days to a few
weeks. In general this is not a limitation, as the transgene(s)
drive(s) the synthesis of the protein(s) under study for
enough time to successfully carry on the majority of ex vivo
experiments.
Biological Vectors
Viruses
Viruses have a natural capability to cross the cellular membrane
during infection. For transfection, viral vectors need to be
somewhat modified so that they lose the capability to replicate
and cannot destroy infected cells.
The viruses used for gene transfer and stable transfection are
Retroviruses, Adeno-associated viruses (AAVs), and Lentiviruses.
RNA is the genetic material in Retroviruses. Retroviruses infect
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FIGURE 1 | Simplified schematic representations of the effects of the slicing procedure on the preparation of acute slices (left) and OCs (right) from cerebral cortex
(A, B), hippocampus (C, D), and cerebellum (E,F). Only the main components of circuitry are depicted as well as the principal afferent and efferent connections. The
lines of section (solid black bars) of the main fiber systems are represented only in the right panels to show the effects of resection onto the afferent and efferent
systems (shadowed in comparison to the corresponding drawings at left). The magenta neurons in E, F represent the external granular layer of the cerebellar cortex, a
temporary subpial cell layer that disappears in the mature cerebellum. CN, cerebellar nucleus; CA1, CA3, hippocampal subfields CA1 and CA3 (from Cornu
Ammonis); DG, dentate gyrus; ION, inferior olivary nucleus; LSN, lateral septal nucleus.
only mitotic cells and, therefore, are not suitable for neuronal
transfection. The foamy viruses, a subgroup of Retroviruses,
are, however, suitable for transfecting the nerve cells (30).
Lentiviruses infect both mitotic and non-mitotic cells. They can
thus be employed for stable gene transfer in non-dividing mature
neurons. To block protein translation it is possible to use a
lentivirus that delivers a short hairpin RNA (shRNA) to the
transfected cell for obtaining a continual knockdown of gene
expression. Using an on-off system with inducible lentiviruses it
is possible to dissect out very precisely gene function in targeted
neurons (31). TheHerpes simplex viruses (HSVs) are neurotropic
viruses. Their DNA does not integrate into the host genome,
but, once introduced into the cell nucleus, it remains there for
very long periods and forms an independent fragment of circular
DNA that duplicates upon division of the host cell. Therefore,
HSVs are particularly useful for long-term experiments.
Adenoviruses possess a double-stranded DNA (dsDNA),
whereas in AAVs the genetic material is a single-stranded
DNA (ssDNA). These two types of viruses are effective in
neuronal transfection as they efficaciously infect both dividing
and non-dividing cells. In neurons, Adenoviruses can be
employed for transient transfection, whereas the AAVs yield
stable transfection.
As viruses usually harbor only a modest quantity of genetic
material, some genes are too big to be integrated into the viral
genome for transfection. This is obviously a serious drawback of
this type of vectors.
Plasmids
Plasmids are the most widely-used vectors for DNA transfection
of isolated neurons or OCs. Plasmids, also referred to as extra-
chromosomal DNAs, consist of a circular dsDNA molecule
Frontiers in Veterinary Science | www.frontiersin.org 5 July 2018 | Volume 5 | Article 164
Lossi and Merighi Brain Slices and the 3Rs
FIGURE 2 | Simplified schematic representations of the effects of the slicing procedure on the preparation of acute slices (left) and OCs (right) from spinal cord (A,
B) and retina (C, D). Only the main components of circuitry are depicted as well as the principal afferent and efferent connections. In spinal cord (A, B) just the
interneurons in the superficial dorsal horn and the ventral horn motor neurons are portrayed as the intralaminar and interlaminar circuitries are particularly complex and
still not fully understood. The lines of section (solid black bars) of the main fiber systems are represented only in the right panels to show the effects of resection onto
the afferent and efferent systems (shadowed in comparison to the corresponding drawings at left). DRG, dorsal root ganglion.
that remains independent from the host’s chromosomal DNA.
Their length ranges from a few thousand bp to more than 100
kbp. Plasmids may parasitize or live in symbiosis with yeasts,
bacteria, or few cell types from eukaryotes. Before every cell
division, both the host-cell chromosomal DNA and the plasmid
DNA are duplicated. Then, at cytodieresis, the plasmid DNA is
distributed between the two daughter cells, so that the genetic
material is propagated along sequential cell generations (32).
A great advantage of plasmid vectors is that they can host
DNA constructs of small to very big sizes, up to about 20
kbp. However, differently form viruses, plasmids cannot actively
penetrate cells and must be delivered by means of ad hoc
transfection procedures. The naked DNAs make an exception to
this general rule. They are particular plasmids capable to cross the
cell membrane of at least some types of neurons. Transfection
efficiency is low in naked DNAs, but it can be augmented to
an high degree by physical means such as ultrasounds and
microbubbles (33).
Synthetic Vectors
Numerous non-biological (synthetic) nanomolecules, such as
cationic liposomes, cationic polymers, dendrimers, cyclodextrin,
and cell-penetrating peptides (CPPs), can be employed for
DNA and RNA delivery to CNS (34). Synthetic vectors are not
cytotropic and are more or less cytotoxic. Synthetic vectors are
generally used to transfect individual cells after dissociation from
tissue explants and/or cell lines, and can be employed in vivo after
systemic delivery for gene therapy studies (34), or by stereotaxic
microinjection in site-specific studies (35, 36). Those most in use
are cationic liposomes and cationic polymers.
In water, cationic lipids arrange themselves into spheroidal
structures delimited by a double lipid layer and referred to as
liposomes (37, 38). When liposomes get in contact with DNA
or RNA, they form complexes (lipoplexes) with these molecules.
Eukaryotic cells can actively endocytose the lipoplexes, and
eventually internalize them within endosomes. Lipoplexes then
fuse with the endosomal membrane and are released into the
cytosol. Endosomal escape is the capability of a lipoplex to get-
away from endosomes. It is one of the most prominent attributes
of an efficient synthetic transfection reagent, as the endosomal
escape directly correlates with the ability of a given liposome
to release its nucleic acid cargo after having been internalized
into the host cell. Liposomes can host DNAs or RNAs without
limits of molecular size. Cationic liposomes are liposomes made
with cationic lipids or obtained after mixing cationic and neutral
lipids. They are very cheap to be prepared and display high
transfection efficiencies. This explains why cationic liposomes are
much diffused in the market.
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Polyethylenimine (PEI) and poly-lysine are cationic polymers
with a favorable endosomal escape (35, 39, 40). Their structure
can be linear or branched, and size strongly affects the
transfection efficiency of individual polymers (36, 41, 42).
Biolistic Transfection
Biolistic transfection (43) relies on a simple physical (mechanical)
principle whereby the non-native nucleic acid is introduced into
the cells after it is accelerated to acquire enough kinetic energy for
crossing their membrane. Usually a plasmid DNA is employed
in this type of transfection procedure. The plasmid carries a
cDNA sequence of interest and is adsorbed onto the surface of
an inert colloidal gold particle that acts as an inactive substance
that is a vehicle for the DNA to enter the cell. By this means,
the DNA (complexed with gold) reaches a sufficient mass to be
propelled by a helium blast and to perforate the cell membrane
(44).
Several advantages are associated to the use of biolistics to
transfect neurons in OCs. First, only a relatively small amount
of DNA, in comparison with other procedures, is necessary
for successful transfection. Second, multiple transfections (co-
transfection) with different DNAs are easily performed (45,
46). Third, the procedure has high efficiency both ex vivo and
in vitro. Major limitations are the poor penetration of the
DNA-gold complex in thick slices and the potential damage to
the cell that may eventually die as a consequence of physical
overload. Biolistic transfection is very expensive, this being
another disadvantage of the procedure.
For animal cell transfection, gold of 1–1.5µm in diameter
(1µm is, in general, the size of choice) can be used as they do
not display obvious differences in efficiency. Comparable labeling
efficiency andminimal tissue damage was reported after neuronal
transfection with ultra-small gold particles around 40 nm (47).
Constructs and Reporter Molecules
Broadly speaking, transfection methods allow performing two
different groups of experiments onto cultured neurons.
One group relies on the classic principles of protein
genetic engineering and was the first to be developed. Genetic
engineering permits to alter the customary way of operation
or behavior of one (single transfection) or more (multiple
transfection) proteins inside the cell, this being its most
important advantage to the understanding of protein function.
Just to give a few examples, it may be possible to overexpress
the protein (48), or to reduce/abolish translation by RNA
interference (45), or to make neurons synthesizing an alien
protein, e.g., a receptor type or subunit that is not normally
expressed by that particular type of cell. Altogether, these
procedures permit to understand the role of a protein on
cell survival, physiology, and pathology. The other group of
experiments aims to profit of some distinctive features of the
protein artificially introduced into the nerve cell. In the easier
use, it is possible to label a given type of neuron by making it to
produce a reporter molecule, i.e., a protein that can be seen with
ease in the microscope or measured by biochemical approaches.
To adequately control the reporter’s synthesis it is mandatory to
employ a general or a cell-specific promoter, according to needs.
Reporter molecules are of very different nature, but FRPs are
among the more widely diffused.
FRPs exist in different colors: green (green fluorescent
protein—GFP), yellow (yellow fluorescent protein—YFP and
enhanced YFP - EYFP), red (red fluorescent proteins—RFPs,
e.g., DsRed), cyan (cyan fluorescent protein—CFP) and more
others. Their numerous variants and mutations are today widely
in use as they are amenable to live imagining by several
types of fluorescence microscopies (49). FRPs are genetically-
encoded fluorescent dyes (GEFDs) that not only label with
multiple colors specific populations of neurons, but are of
paramount importance in understanding neuronal physiology
(50). The most important GEFDs that are in use or have a
great potential to be used in OCs experiments can be grouped
in five main types, according to their principle of functioning
and/or type of information that they permit to achieve. They
are briefly described below for a better comprehension of
the perspectives for expanding the use ex vivo platforms in
neuroscience studies that will be discussed in the following
section.
Fluorescence resonance energy transfer (FRET) probes
(consisting e.g., of a pair of FRPs made of the Venus variant of
YFP and CFP). The pair can be put together (with FRET) or
disjointed (without FRET) by the breaking of a chemical bond in
a protein, or as a consequence of a mutual or reciprocal chemical
interaction between a ligand and its receptor or two different
regions of the same molecule, or after a protein modifies its
conformation). FRET is very important as it may be quantified
(45, 51, 52).
Genetically encoded calcium indicators (GECIs) comprise a
number of proteins that sense calcium inside the cell (GCaMP6).
Today’s GECIs are very sensitive and specific and can detect also
very rapid calcium changes (53).
Optogenetic sensors can be used to study calcium (Aequorin,
Cameleon, GCaMP) or chloride (Clomeleon) fluxes and
membrane voltage (54–56).
Genetically-encoded voltage indicators (GEVIs) are voltage-
sensitive fluorescent proteins (VSFPs) of second (VSFP2s) or
third generation (VSFP3s). The first consist of the voltage-
sensing domain of a protein isolated by the ascidian Ciona
intestinalis. The protein is impermeable to calcium, but its voltage
sensor is a phosphatase that cuts a FRET pair and thus yields a
measurable signal when the intracellular calcium concentration
changes as a consequence of a biological event (57). VSFP3s,
instead, operate through a FRET-independent mechanism
(58, 59).
Dark-to-bright state fluorescent biosensors are normally not
fluorescent (silent or dark state), but can be rendered fluorescent
(bright state) by protein cleavage. Among these biosensors is a
type of GFP where fluorescence is fully suppressed by a peptide.
As this peptide can be detached from GFP by a protease, the
biosensor can be used to study proteolysis in live neurons (60,
61).
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FIGURE 3 | Example of the potential for reduction in the number of experimental animals using slice platforms for ex vivo studies. The example is based on the
theoretical possibility to use the entire mouse spinal cord after coronal sectioning at a thickness of 400µm. Rostro-caudal length of the cord is 32mm at postnatal day
56 and 16mm at postnatal day 4 (63). In theory it is possible obtaining up to 80 sections/animal (32,000:400) at P56, but a more reliable estimate is around 40
sections/animal. In P4 mice, corresponding figures are 40 (16,000:400) and 20 sections, respectively. It is then possible to cultivate 3–5 slices in 3 cm culture dishes,
so that each culture is treated under different experimental conditions. The percentage of reduction thus goes from 75% (P4) to 87.5% (P56).
PERSPECTIVES FOR EXPANDING THE
USE EX VIVO PLATFORMS IN
NEUROSCIENCE STUDIES
Reduction of Animal Number
Abatement of the amount of experimental animals is the
main advantage in the use of OCs in neuroscience (62). With
substantial differences related to the sources of the slices to be
subsequently cultivated ex vivo, from one to several tens of fully
viable slices can be obtained from a single animal. We have
recently estimated that the potential for reduction in our model
of spinal cord inflammation may reach 75%, when the P4 spinal
cord is put in culture, up to more than 85%, in the case of the
adult spinal cord (see Figure 3). Reduction not only is linked to
the possibility to cut down the number of subjects euthanized, but
also to use slices/OCs obtained from a single animal in several
different experiments. In addition, use of slices or OCs raises
moderate ethical concerns, because there is no impact on welfare
as animals are simply subjected to euthanasia (62).
Refinement of Procedures
Pain and/or distress that are often associated to the most
widely used experimental paradigms in neuroscience research are
reduced to a minimum (the euthanasic procedure) to prepare
slices or OCs, in accordance with the principle of refinement
(Table 1). The most relevant applications of OCs under this
perspective are discussed below.
Axon Regeneration and Reconstruction of Circuitries
One of the most important areas of investigation in neuroscience
research aims to understanding the mechanisms of axon
regeneration and to promote the reconstruction of neuronal
circuitries lesioned as e.g., consequence of a traumatic event. This
is very often performed in vivo together with more or less heavy
surgical manipulations, severe postoperative consequences, loss
of sensorimotor and/or cognitive functions, distress and pain.
As mentioned, the slicing procedure necessary to prepare the
OCs is always associated with the interruption of afferent and/or
TABLE 1 | Refinement of procedures in ex vivo platforms.
Type of experiment In vivo Ex vivo
Cut (deafferentation/deefferentation)
and reconstruction of neural
connections (nerve regeneration)
Severe (invasive and painful
surgery)
Non-recovery
Traumatic lesion Compression/constriction
injury
Non-recovery
Administration of drugs Moderate (parenteral
injection)
Severe (intraventricular or
intrathecal injection)
Non-recovery
Studies on neurotoxicity Severe Non-recovery
Release of biologically active
molecules
Severe (microinjection or
microelectrode implant)
Non-recovery
Induction of inflammation Moderate (intradermic
injection)
Severe (intrathecal injection)
Non-recovery
Severity is indicated according to current EU regulations (DIRECTIVE 2010/63/EU OF
THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 22 September 2010 on the
protection of animals used for scientific purposes).
efferent connections. This, at first sight, may appear as one of the
major limitations to implement the use of ex vivo platforms as an
alternative to in vivo. However, one can take advantage of target
disconnection to study neuroprotection and axon regeneration in
two main experimental paradigms (Figure 4).
In the first, neurotrophic factors or other putative protective
drugs can be added to OCs so that is possible to assess whether
these substances may indeed promote neuronal survival and/or
axonal growth (Figure 4A). The second option is to use co-
cultures of slices obtained from two different regions originally
connected to each other and to analyse e.g., the regenerative
properties of the molecule(s) of interest (Figure 4B).
Protection of axotomized neurons
OCs are valuable tools to study the neuroprotective effects against
axotomy-induced cell death (Figure 4A). Several examples can
be given to illustrate this type of experiments in slices obtained
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FIGURE 4 | Use of OCs in the study of axon regeneration and reconstruction of circuitries. (A) Assessment of drug neuroprotective activity on axotomized neurons in
OCs; (B) Co-culture of two brain slices. One of the two slices (OC1–source) contains the parent cell bodies of the axons connected with the other slice (OC2–target).
These connections are intentionally cut in the preparation of the explant and axonal regeneration is followed in OC2 under control conditions (spontaneous
re-innervation) or after pharmacological treatments. In the example, neurons in OC1 are made fluorescent by genetic engineering so that their axons can be easily
traced in OC2.
from hippocampus (64), hypothalamus (65, 66), basal nucleus of
Meynert–BNM (23, 67), substantia nigra -SN (68, 69), cerebellum
(70–72), retina (73) and DRGs (74). It is interesting to recall here
that degeneration of dopaminergic SN neurons and cholinergic
BNM neurons is strictly related to development of Parkinson’s
and Alzheimer’s disease, respectively, and that, very recently,
a new rat model of Huntington’s disease consisting of coronal
slices including all the brain regions that may be hit by the
pathology has been developed (75). In addition, OCs have been
proposed as important tools for medium-throughput screening
in neurotoxicological studies (76–78).
Reconstruction of axonal connections
To date, OCs are already employed in regeneration studies
of neural circuitries. Co-cultures of two (or more) in
vivo (inter)connected areas of the brain are established to
pharmacologically screen the capability of specific molecules to
promote axonal growth and rewiring (Figure 4B). References
to organotypic co-cultures for studies published before 2009
can be found in Table 1 from Lossi et al. (6). Other more
recent reports have been published on the regeneration of
specific connections such as those between the sensorimotor
cortex and spinal cord (79), the hippocampus and septum (80),
the ventral tegmental/area SN and prefrontal cortex/striatum
(81, 82). Very interesting, pharmacological screening of
molecules promoting axon regeneration was also performed
using entorhino-hippocampal (EH) organotypic co-cultures in
which the degree of axonal regeneration after EH axotomy was
evaluated using entorhinal slices obtained from enhanced green
fluorescent protein (EGFP)+ transgenics so that regenerating
axons were fluorescent (83). A recent study has also developed
a two-compartment OC to study nerve recovery after injury
(84).
Studies on Neuroactive/Neuroprotective Drug
Candidates and Neurotoxic Substances
An enormous amount of studies has been and still is
devoted to the discovery, synthesis, and characterization of
neuroactive substances and/or neuroprotective molecules that
have a potential for pharmacological applications. In relation
to the principle of Refinement, the benefit of OCs should be
considered also under the perspective that most experimental
paradigms of this type require induction of experimental
neurodegeneration/neuropathology so that live animals and/or
transgenic models are first subjected to a heavy treatment in
biological and ethical terms (Table 1). Still, current use of
OCs raises two important issues. First, slice experiments are
often carried out using pharmacological concentrations of the
drugs to be tested and offer very limited hints as to the true
capability of these drugs/molecules to exert an effect, if any, at
concentrations that better mimic those to which neurons may
be physiologically exposed in vivo. Second, they do not permit
assessing the capability of the substance(s) under study to cross
the BBB.
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FIGURE 5 | Use of a cell line/primary cells producing a bioactive molecule to assess the effects of its physiological release ex vivo. Cells producing the biologically
active molecule (red dots) can be made fluorescent by genetic engineering (A–C) and directly microinjected into the slice (A), seeded at the top of the OC
(B), supported by a scaffold (C), or seeded at the bottom of culture dish (D).
Perspectives for the use of acute slices or OCs in
medium-throughput screening
As a future direction, we propose more sophisticated approaches
for using OCs in medium-throughput screening studies. Two
main lines of application can be envisaged and discussed as
follows.
Pharmacological and physiological screening of neuroactive
molecules. Currently, molecule(s) to be tested in vitro
is (are) added at different concentrations to culture
medium and its (their) effects tested using biochemistry
(chromatography, enzyme activity assays), immunochemistry
(immunocytochemistry, Western blotting, ELISA), or molecular
biology (PCR, RT-PCR, FRET, etc.). With such approaches, it
is by no means demonstrable that concentrations giving rise
to measurable effects in vitro can be effectively reached in vivo
following physiological cellular release or pharmacological
administration.
We are currently exploring the use of primary cells and/or
cell lines releasing the molecule(s) of interest in the culture
medium, physiologically, or after genetic manipulation. Ideally
these cells should be made fluorescent to trace their survival and
fate within OCs (Figure 5). In practice, fluorescently tagged cells
can be directly microinjected (Figure 5A) or seeded (Figure 5B)
on the top of OCs. It may also be possible to use an ad hoc
scaffold to support the foreign cells (Figure 5C) or to seed the
cells releasing the molecule of interest at the bottom of the
culture dish (Figure 5D). As an example of the use of a scaffold
to support and promote the growth of primary cells onto OCs,
dopamine-producing human induced-neuronal cells encased in
a scaffold were successfully grafted into cortico-striatal OCs, with
an amelioration of the growth of processes and increase in the
rate of action potentials, when compared to individual cells after
dopamine microinjection (85). Scaffolds are also of interest as
they offer the possibility to reconstruct ex vivo the BBB.
Other approaches already in use for cultures of isolated
cells, rely on multiplexing technologies such as Luminex
xMAP R© multi-analyte profiling, which enables the simultaneous
detection, and quantitation of multiple secreted proteins in
culture medium and are useful to study the dynamic response
of nerve cells to experimentally induced perturbations (86).
This high-throughput technology produces results comparable
to ELISA but with lower costs, greater efficiency, speed, and
dynamic range. Similarly to xMAP R©, xTAG R© allows easy
development/optimization of nucleic acid mid-density arrays
that permit evaluating genotypes, gene expression, or miRNAs.
However, both approaches have not been used yet in slice or OC
applications.
Other interesting opportunities for a more widespread use
of OCs are based on the possibility to transfect them with
fluorescent probes of various nature (44). Among these, FRET
probes permit to study protein-to-protein interactions, proteases
(45) or promoters’ activity in live cells. With optogenetic
probes, instead, individual neurons or neural networks can
be activated with flashes of blue light (87). As an example of
the potential applications of these probes in pharmacological
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FIGURE 6 | Strategy for developing a new ex vivo platform to study the effect
of a neurotropic factor. The example describes a co-culture made of an acute
or organotypically cultured brain slice and a monolayer of sniffer cells seeded
at the bottom of a Petri dish. If an acute slice is used it needs to be kept in
place with an ad hoc grid (not represented for simplicity). (A) engineering of the
sniffer cell line to make it suitable for reporting the release of BDNF from slice
cells. The sniffer cells are double transfected to express trkB receptors and a
dark-to-bright state GFP-based biosensor (60, 61) that is modified to become
activated after trkB phosphorylation. (B,C) Scheme of the co-culture set-up. In
(B) the sniffer cells are not fluorescent, whereas in (C) the BDNF released from
the slice (red dots) diffuses through the culture medium, binds to trkB
receptors on the sniffer cells and thus some of these cells become fluorescent.
The process can be imagined in real time using an inverted wide field or
confocal microscope. In the example it is assumed that BDNF release is
triggered after an ad hoc stimulus.
studies, transplanted dopaminergic neurons differentiated
from neural stem cells were demonstrated to functionally
integrate in OCs derived frommice with experimentally-induced
Parkinson (88).
Screening endogenous release. If one is interested in assessing
the capability of cultured cells to release one or more bioactive
molecules at physiologically relevant concentrations, we propose
to use co-cultures made of an OC and a monolayer of responsive
“sniffer” cells capable to bind the molecule(s) under study
after interaction with specific receptors and to report ligand
binding through a fluorescent tag (Figure 6). Activatable GFP, a
unique chromophore that remains in a “dark” state because its
maturation is inhibited (89) can be used as a reporter molecule.
Alternatively, activity based fluorescence biosensors are also
interesting (49, 90). Biosensors may e.g. use FRET (91) or consist
of polypeptide sequences which undergo a specific physico-
chemical modification by the target enzyme, which affects probe
fluorescence (90). A very important application lies in non-
destructively imaging of tyrosine kinase activities with high
spatial and temporal resolution in single living cells to study
protein phosphorylation (91). As an example of the potential
associated with these probes, we describe in Figure 6 our strategy
to monitor ex vivo the release and biological activity of brain-
derived neurotrophic factor (BDNF).
STATISTICAL DESIGN AND DATA
ROBUSTNESS IN TRANSLATIONAL
STUDIES USING RODENT EX VIVO
PLATFORMS
One of the main issues in the use of ex vivo platforms in
neuroscience translational studies regards the soundness and
reproducibility of data particularly if one wants to employ these
platforms in screening studies as tools for drug development,
as there is a strong need to work out instruments that are
accepted by regulatory authorities (92). This issue is of more
general interest to the point that the European College of
Neuropsychopharmacology (ECNP) has promoted, in the
recent past, the creation of a Preclinical Data Forum Network
(https://www.ecnp.eu/research-innovation/ECNP-networks/
List-ECNP-Networks/Preclinical-Data-Forum.aspx).
Among the problems that are recognized to be of primary
importance in producing reliable and translationally useful data
are those related to poor experimental design and statistical
analysis. As reported in a recent publication of the network
“There is ample evidence that technical issues are the major
drivers. Studies are under-powered, do not follow appropriate
blinding and randomization procedures, contain overtly flexible
study designs (e.g., insufficiently defined endpoints), use
poor statistics and demonstrate an over-reliance on P-values
(93)”.
If one wants to propose brain slices as alternatives to
animal experiments in drug screening, choices in statistical
analysis must be strictly performed according to a previously
carefully established experimental plan. If not, results cannot be
considered at face value. Sample size (i.e., number of animals,
number of slices/animal and number of slice/treatment) must
be chosen in advance and not adjusted to the results of initial
statistics. It was e.g., calculated that there is a 5% chance of error
when more data are collected only after a P > 0.05 resulted
from a first set of experiments (94). Other common mistakes
are HARKing (Hypothesizing After the Result is Known) a term
introduced by Kerr (95), and the wrong conception that P-values
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give information on effect size, whereas they strictly depend on
sample size and must be carefully analyzed in each experimental
context (94).
Finally, false positives (type I errors) are very important: if
one screens lightly pre-screened molecules expecting that 10% of
them indeed have an effect, at 0.80 statistics power and P set at
5% there is a 36% probability to obtain a false positive result (94).
CONCLUDING REMARKS
Animal studies still represent a pillar in neuroscience
research. The continuous development and amelioration
of ex vivo approaches will be undoubtedly important in
developing new versatile screening tools for translational
neuropsychopharmacology and neuroprotective strategies
(96, 97). Therefore, in parallel with today’s possibility to
genetically manipulate slices directly after explant by transfection
techniques, OCs also have a potential to further expand in
neuroscience research.
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